title: The perioperative use of ceftriaxone as infection prophylaxis in neurosurgery.
abstract: An open label study was conducted in the department of neurosurgery, Beijing Tiantan Hospital in China to determine the incidence of postoperative infections following the use of one or two doses of ceftriaxone administered perioperatively. A total of 343 patients, who required neurosurgery and had satisfied the inclusion criteria, was recruited during a 12 month study period. Of these 343 patients, there were 97 and 107 cases of malignant and benign tumours, respectively, 52 cases of aneurysm, 34 cases of arteriovenous malformation, and 53 other cases who underwent neurosurgery for drainage of sub-dural haematoma, relief of cerebral oedema and other indications. A total of 6 (1.75%) cases of postoperative infection was observed, of which 4 were found in the malignant tumour group, and 2 in the arteriovenous malformation group. All six patients were suffering from meningitis. During the 12 month period immediately prior to the present study, when postoperative penicillin and gentamicin was administered twice daily for 5-7 days as regular prophylaxis against infection, the incidence of postoperative infection was 7.2% in the same department managed by the same staff. Results of our present study suggest that one to two doses of ceftriaxone administered perioperatively are effective in reducing the rate of postoperative infections.
authors.affiliation: Department of Neurosurgery, Beijing Tiantan Hospital, China.
authors.forename: J Z
authors.initials: JZ
authors.lastname: Zhao
authors.forename: S
authors.initials: S
authors.lastname: Wang
authors.forename: J S
authors.initials: JS
authors.lastname: Li
authors.forename: J
authors.initials: J
authors.lastname: Yang
authors.forename: J T
authors.initials: JT
authors.lastname: Zang
authors.forename: Q
authors.initials: Q
authors.lastname: He
authors.forename: L L
authors.initials: LL
authors.lastname: Shao
authors.forename: Z X
authors.initials: ZX
authors.lastname: Dai
authors.forename: H Y
authors.initials: HY
authors.lastname: Chao
authors.forename: K C
authors.initials: KC
authors.lastname: Lau
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000517:prevention & control*; D001812:Blood-Brain Barrier / Q000187:drug effects; D001921:Brain / Q000601:surgery*; D002443:Ceftriaxone / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009493:Neurosurgery; D011182:Postoperative Care; D013210:Staphylococcus / Q000187:drug effects
chemical_list: D000900:Anti-Bacterial Agents; D002443:Ceftriaxone